Materials and methods for delivery of biological drugs.
暂无分享,去创建一个
[1] マティヤシェフスキ,クシシュトフ,et al. Atom Transfer Radical Polymerization , 2016 .
[2] N. Binkley,et al. A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: The oral calcitonin in postmenopausal osteoporosis (ORACAL) trial , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[3] Chun Xing Li. Poly(L-glutamic acid)--anticancer drug conjugates. , 2002, Advanced drug delivery reviews.
[4] Allon I Hochbaum,et al. Rational design of cytophilic and cytophobic polyelectrolyte multilayer thin films. , 2003, Biomacromolecules.
[5] J. Andersen,et al. Structure-based mutagenesis reveals the albumin-binding site of the neonatal Fc receptor , 2012, Nature Communications.
[6] G. Scheuch,et al. Treatment of systemic diseases by inhalation of biomolecule aerosols. , 2009, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[7] V. Torchilin. Intracellular delivery of protein and peptide therapeutics. , 2008, Drug discovery today. Technologies.
[8] Samir Mitragotri,et al. Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies , 2014, Nature Reviews Drug Discovery.
[9] H. Maeda,et al. Evaluation of Poly(vinyl alcohol) for Protein Tailoring: Improvements in Pharmacokinetic Properties of Superoxide Dismutase , 1993 .
[10] F. Caruso,et al. Poly(vinylpyrrolidone) for bioconjugation and surface ligand immobilization. , 2007, Biomacromolecules.
[11] D. M. Lynn,et al. Reduction of intimal hyperplasia in injured rat arteries promoted by catheter balloons coated with polyelectrolyte multilayers that contain plasmid DNA encoding PKCδ. , 2013, Biomaterials.
[12] K. Shakesheff,et al. Polymeric systems for controlled drug release. , 1999, Chemical reviews.
[13] C. Gu,et al. Extension of in vivo half-life of biologically active peptides via chemical conjugation to XTEN protein polymer. , 2013, Protein engineering, design & selection : PEDS.
[14] Y. Ikada,et al. Fate of water-soluble polymers administered via different routes. , 1995, Journal of pharmaceutical sciences.
[15] D. M. Lynn,et al. Polyelectrolyte multilayers promote stent-mediated delivery of DNA to vascular tissue. , 2013, Biomacromolecules.
[16] Paula T Hammond,et al. Tunable dual growth factor delivery from polyelectrolyte multilayer films. , 2011, Biomaterials.
[17] B. Sarmento,et al. Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: A review , 2014 .
[18] D. Mooney,et al. Biomaterial-based delivery for skeletal muscle repair. , 2015, Advanced drug delivery reviews.
[19] Keith M. McLean,et al. Cryogels for biomedical applications. , 2013, Journal of materials chemistry. B.
[20] Albert H. L. Chow,et al. Particle Engineering for Pulmonary Drug Delivery , 2007, Pharmaceutical Research.
[21] Asher Mullard,et al. Maturing antibody–drug conjugate pipeline hits 30 , 2013, Nature Reviews Drug Discovery.
[22] R. Doyle,et al. Traveling the vitamin B12 pathway: oral delivery of protein and peptide drugs. , 2009, Angewandte Chemie.
[23] Myron Spector,et al. Surface-Mediated Bone Tissue Morphogenesis from Tunable Nanolayered Implant Coatings , 2013, Science Translational Medicine.
[24] R. Ross,et al. Developing long‐acting growth hormone formulations , 2013, Clinical endocrinology.
[25] V. Khutoryanskiy. Advances in mucoadhesion and mucoadhesive polymers. , 2011, Macromolecular bioscience.
[26] L. Brown. Commercial challenges of protein drug delivery , 2005, Expert opinion on drug delivery.
[27] D. Discher,et al. Cell responses to the mechanochemical microenvironment--implications for regenerative medicine and drug delivery. , 2007, Advanced drug delivery reviews.
[28] A. Metters,et al. Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: Engineering cell-invasion characteristics , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[29] Jung-Hwan Park,et al. Microneedles for drug and vaccine delivery. , 2012, Advanced drug delivery reviews.
[30] K. Seyfarth,et al. PASylation of Murine Leptin Leads to Extended Plasma Half-Life and Enhanced in Vivo Efficacy. , 2015, Molecular pharmaceutics.
[31] Leslie R Evans,et al. Albumin as a versatile platform for drug half-life extension. , 2013, Biochimica et biophysica acta.
[32] M. Schenerman,et al. Advances in the assessment and control of the effector functions of therapeutic antibodies , 2011, Nature Reviews Drug Discovery.
[33] En-Wei Lin,et al. Therapeutic protein-polymer conjugates: advancing beyond PEGylation. , 2014, Journal of the American Chemical Society.
[34] S. Mitragotri,et al. Safe and Effective Permeation Enhancers for Oral Drug Delivery , 2008, Pharmaceutical Research.
[35] G. Koenig,et al. Selective and uncoupled role of substrate elasticity in the regulation of replication and transcription in epithelial cells , 2010, Journal of Cell Science.
[36] Mark R Prausnitz,et al. Separable arrowhead microneedles. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[37] Joyce Y. Wong,et al. Directed Movement of Vascular Smooth Muscle Cells on Gradient-Compliant Hydrogels† , 2003 .
[38] S. Clement,et al. Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: the glucose stabilization effects of HIM2. , 2002, Diabetes technology & therapeutics.
[39] Hong Tan,et al. The influence of arrangement sequence on the glucose-responsive controlled release profiles of insulin-incorporated LbL films. , 2012, Acta biomaterialia.
[40] F. Davis. The origin of pegnology. , 2002, Advanced Drug Delivery Reviews.
[41] João Rodrigues,et al. Injectable and biodegradable hydrogels: gelation, biodegradation and biomedical applications. , 2012, Chemical Society reviews.
[42] Tejraj M Aminabhavi,et al. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[43] R. Luxenhofer,et al. On the biodegradability of polyethylene glycol, polypeptoids and poly(2-oxazoline)s. , 2014, Biomaterials.
[44] S. Sen,et al. Matrix Elasticity Directs Stem Cell Lineage Specification , 2006, Cell.
[45] Graeme Moad,et al. Living radical polymerization by the RAFT process , 2005 .
[46] J. Hanes,et al. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. , 2009, Advanced drug delivery reviews.
[47] A. Zelikin,et al. Drug releasing polymer thin films: new era of surface-mediated drug delivery. , 2010, ACS nano.
[48] G. Scheuch,et al. Systemic treatment by inhalation of macromolecules--principles, problems, and examples. , 2008, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[49] J. Hubbell,et al. Drug development: longer-lived proteins. , 2012, Chemical Society reviews.
[50] V. Lozinsky,et al. Swelling behavior of poly(vinyl alcohol) cryogels employed as matrices for cell immobilization , 1996 .
[51] Mark R. Prausnitz,et al. Layer-by-layer assembly of DNA- and protein-containing films on microneedles for drug delivery to the skin. , 2010, Biomacromolecules.
[52] L. Heinemann,et al. Oral Insulin and Buccal Insulin: A Critical Reappraisal , 2009, Journal of diabetes science and technology.
[53] P. Schaaf,et al. Small vessel replacement by human umbilical arteries with polyelectrolyte film-treated arteries: in vivo behavior. , 2008, Journal of the American College of Cardiology.
[54] J. DeSimone,et al. Potent engineered PLGA nanoparticles by virtue of exceptionally high chemotherapeutic loadings. , 2011, Nano letters.
[55] K. Amighi,et al. Formulation strategy and use of excipients in pulmonary drug delivery. , 2010, International journal of pharmaceutics.
[56] Willem P C Stemmer,et al. A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner , 2009, Nature Biotechnology.
[57] K. Matyjaszewski,et al. Atom transfer radical polymerization. , 2001, Chemical reviews.
[58] U. Schubert,et al. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. , 2010, Angewandte Chemie.
[59] D. Seliktar. Designing Cell-Compatible Hydrogels for Biomedical Applications , 2012, Science.
[60] A. Dierich,et al. Bone Formation Mediated by Synergy‐Acting Growth Factors Embedded in a Polyelectrolyte Multilayer Film , 2007 .
[61] Anita Shukla,et al. Hemostatic Multilayer Coatings , 2012, Advanced materials.
[62] P. Taupin,et al. PEG and PEG conjugates toxicity: towards an understanding of the toxicity of PEG and its relevance to PEGylated biologicals , 2009 .
[63] Zhifeng Shao,et al. Fc-fusion proteins: new developments and future perspectives , 2012, EMBO molecular medicine.
[64] S. Mitragotri,et al. Discovery of synergistic permeation enhancers for oral drug delivery. , 2008, Journal of Controlled Release.
[65] L. B. Knudsen,et al. Structure-activity and protraction relationship of long-acting glucagon-like peptide-1 derivatives: importance of fatty acid length, polarity, and bulkiness. , 2007, Journal of medicinal chemistry.
[66] M. Tabrizian,et al. Nanocoatings onto arteries via layer-by-layer deposition: toward the in vivo repair of damaged blood vessels. , 2003, Journal of the American Chemical Society.
[67] R. Langer,et al. Transepithelial Transport of Fc-Targeted Nanoparticles by the Neonatal Fc Receptor for Oral Delivery , 2013, Science Translational Medicine.
[68] G A Harrison,et al. INSULIN IN ALCOHOLIC SOLUTION BY THE MOUTH , 1923, British medical journal.
[69] Peter R. Byron,et al. Inhaling medicines: delivering drugs to the body through the lungs , 2007, Nature Reviews Drug Discovery.
[70] J. Remon,et al. Layer-by-layer incorporation of growth factors in decellularized aortic heart valve leaflets. , 2010, Biomacromolecules.
[71] Mark Gumbleton,et al. Challenges in inhaled product development and opportunities for open innovation. , 2011, Advanced drug delivery reviews.
[72] P. Caliceti,et al. New synthetic amphiphilic polymers for steric protection of liposomes in vivo. , 1995, Journal of pharmaceutical sciences.
[73] R. Desnick,et al. Enzyme replacement therapy for lysosomal diseases: lessons from 20 years of experience and remaining challenges. , 2012, Annual review of genomics and human genetics.
[74] A. Baas,et al. FDA-approved poly(ethylene glycol)–protein conjugate drugs , 2011 .
[75] A. Seligman,et al. Polyvinyl pyrrolidone as a plasma expander; studies on its excretion, distribution and metabolism. , 1952, The New England journal of medicine.
[76] Robert Langer,et al. Microfluidic platform for controlled synthesis of polymeric nanoparticles. , 2008, Nano letters.
[77] A. Zelikin,et al. Micro-structured, spontaneously eroding hydrogels accelerate endothelialization through presentation of conjugated growth factors. , 2015, Biomaterials.
[78] Johnson,et al. Preparation of peptide and protein powders for inhalation. , 1997, Advanced drug delivery reviews.
[79] M. Pitsikalis,et al. Synthesis of well-defined polypeptide-based materials via the ring-opening polymerization of alpha-amino acid N-carboxyanhydrides. , 2009, Chemical reviews.
[80] G. Russell-Jones. Use of vitamin B12 conjugates to deliver protein drugs by the oral route. , 1998, Critical reviews in therapeutic drug carrier systems.
[81] D. Rudmann,et al. High Molecular Weight Polyethylene Glycol Cellular Distribution and PEG-associated Cytoplasmic Vacuolation Is Molecular Weight Dependent and Does Not Require Conjugation to Proteins , 2013, Toxicologic pathology.
[82] A. Morrissey,et al. Clinical administration of microneedles: skin puncture, pain and sensation , 2009, Biomedical microdevices.
[83] A. Bernkop‐Schnürch. Thiomers: a new generation of mucoadhesive polymers. , 2005, Advanced drug delivery reviews.
[84] I. Gómez-Orellana,et al. Challenges for the oral delivery of macromolecules , 2003, Nature Reviews Drug Discovery.
[85] J. Leroux,et al. Improving oral drug bioavailability with polycations? , 2015, European journal of pharmaceutics and biopharmaceutics.
[86] R. Langer,et al. Polymers for the sustained release of proteins and other macromolecules , 1976, Nature.
[87] Rudolf Zentel,et al. Overcoming the PEG-addiction: well-defined alternatives to PEG, from structure–property relationships to better defined therapeutics , 2011 .
[88] M. Gumbleton,et al. The particle has landed--characterizing the fate of inhaled pharmaceuticals. , 2010, Journal of aerosol medicine and pulmonary drug delivery.
[89] E. Maggio,et al. High efficiency intranasal drug delivery using Intravail® alkylsaccharide absorption enhancers , 2012, Drug Delivery and Translational Research.
[90] S. Van Vlierberghe,et al. Biopolymer-based hydrogels as scaffolds for tissue engineering applications: a review. , 2011, Biomacromolecules.
[91] R. Langer,et al. Recent advances in pulmonary drug delivery using large, porous inhaled particles. , 1998, Journal of applied physiology.
[92] H. Hsiao,et al. Thermo-induced shape-memory PEG-PCL copolymer as a dual-drug-eluting biodegradable stent. , 2013, ACS applied materials & interfaces.
[93] Molly M. Stevens,et al. Designing Regenerative Biomaterial Therapies for the Clinic , 2012, Science Translational Medicine.
[94] R. Galiano,et al. A review of becaplermin gel in the treatment of diabetic neuropathic foot ulcers , 2008, Biologics : targets & therapy.
[95] Gregory L. Szeto,et al. Structure-based programming of lymph-node targeting in molecular vaccines , 2014, Nature.
[96] M. Grant,et al. Technosphere® Insulin: Defining the Role of Technosphere Particles at the Cellular Level , 2009, Journal of diabetes science and technology.
[97] M. Gänsslen,et al. Über Inhalation von Insulin , 2005, Klinische Wochenschrift.
[98] F. Veronese,et al. PEGylated Protein Drugs: Basic Science and Clinical Applications , 2009 .
[99] T. Kruse,et al. Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide. , 2015, Journal of medicinal chemistry.
[100] F. Plieva,et al. Poly(vinyl alcohol) cryogels employed as matrices for cell immobilization. 3. Overview of recent research and developments , 1998 .
[101] Marcia Simon,et al. Hydrogels for Regenerative Medicine , 2016 .
[102] Kristi S. Anseth,et al. PEG Hydrogels for the Controlled Release of Biomolecules in Regenerative Medicine , 2009, Pharmaceutical Research.
[103] Arne Skerra,et al. PASylation: a biological alternative to PEGylation for extending the plasma half-life of pharmaceutically active proteins , 2013, Protein engineering, design & selection : PEDS.
[104] Felix Kratz,et al. Impact of albumin on drug delivery--new applications on the horizon. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[105] A. Zelikin,et al. Macromolecular design of poly(vinyl alcohol) by RAFT polymerization , 2012 .
[106] R. Auzély-Velty,et al. Polysaccharide-blend multilayers containing hyaluronan and heparin as a delivery system for rhBMP-2. , 2010, Small.
[107] Zhen Gu,et al. Tailoring nanocarriers for intracellular protein delivery. , 2011, Chemical Society reviews.
[108] Andreas Greiner,et al. Electrospinning: a fascinating method for the preparation of ultrathin fibers. , 2007, Angewandte Chemie.
[109] A. Mikos,et al. Strategies for controlled delivery of biologics for cartilage repair. , 2015, Advanced drug delivery reviews.
[110] Dmitry Malkov,et al. Oral delivery of insulin with the eligen technology: mechanistic studies. , 2005, Current drug delivery.